PUBLIC COMPANY
save$MIRMMirum Pharmaceuticals, Inc.
$MIRM97.07-5.06%Foster City, CA, USupdated 7h ago
community read0 votes
pipeline
6
marketed
3
phase 3
1
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(6)
pipeline depth6 products
2Phase 21Phase 33Marketed
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
- —The REPLACE Registry for Cholbam® (Cholic Acid)
- phase2A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
- phase3Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
- phase3Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
- phase3A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
- phase3A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection
- phase3A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 15, 26SELLRamasastry Saira· −$194K↗
- Mar 16, 26SELLPeetz Christopher· CHIEF EXECUTIVE OFFICER−$3.77M↗
- Mar 16, 26SELLRadovich Peter· PRESIDENT AND COO−$1.52M↗
- Mar 16, 26SELLQuan Joanne· CHIEF MEDICAL OFFICER−$670K↗
- Mar 16, 26SELLBJERKHOLT ERIC· CHIEF FINANCIAL OFFICER−$670K↗
- Mar 16, 26SELLHowe Jolanda· SVP, GLOBAL CONTROLLER−$435K↗
- Mar 16, 26SELLRamasastry Saira· −$182K↗
routine RSU / option mechanics (6)
- Apr 15, 26option exerciseRamasastry Saira · 2,000 sh
- Apr 15, 26option exerciseRamasastry Saira · 2,000 sh
- Mar 16, 26option exerciseRamasastry Saira · 2,000 sh
- Mar 16, 26option exerciseRamasastry Saira · 2,000 sh
- Mar 15, 26option exerciseHowe Jolanda · SVP, GLOBAL CONTROLLER6,000 sh
- Mar 15, 26option exercisePeetz Christopher · CHIEF EXECUTIVE OFFICER25,000 sh
🐶 Hiring Signal
next earnings Nov 4, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 15m ago
Found something off?
comments(0)
5-min edit window · permanent after that